公司资料

LadRx 股价、新闻与催化剂

股票代码:
LADX
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

0.01 USD (+1099900.00%)

收盘价

最后更新: 2026年10月2日

—

市值

股价为何变动

目前无法获取 LADX 的收盘价变动背景。

公司概览

业务概览

LadRx was a biotechnology company historically focused on oncology and drug delivery before becoming a legacy ticker. Its story centered on the challenge of turning a narrow therapeutic concept into durable value.

所在地与行业分类

LadRx was headquartered in the United States and traded on NASDAQ. It sat in small-cap oncology and drug-delivery biotechnology.

商业模式特征

The company depended on clinical progress, strategic changes, and capital support while advancing a narrow pipeline. Investors historically watched proof-of-concept and financing runway.

生物医药行业定位

LadRx is best understood as a historical small-cap oncology biotech name. Like many micro-cap drug developers, its stock was driven by pipeline risk and capital needs.

未来催化剂

  • LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update. The market is focused on what value remains.

近期新闻

新闻标题由机器翻译,详情为英文原文。

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。